DYN
DYN clinical trials: Dyne Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Dyne Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 4
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
DYN on the catalyst calendar · DYN registry changes
- Primary completion Jul 2028Sponsor estimatePhase 3NCT07486934Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1Dyne Therapeutics · Myotonic Dystrophy Type 1 (DM1)RecruitingDYNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 2029Sponsor estimatePhase 1/Phase 2NCT05481879Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1Dyne Therapeutics · Myotonic Dystrophy Type 1 (DM1)Active, not recruitingDYNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2031Sponsor estimatePhase 1/Phase 2NCT05524883Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy...Dyne Therapeutics · Duchenne Muscular Dystrophy (DMD)Active, not recruitingDYNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2030Sponsor estimatePhase 3NCT07608432Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory...Dyne Therapeutics · Duchenne Muscular Dystrophy (DMD)RecruitingDYNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2032Sponsor estimateNo phase registeredNCT07700225Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) ExtensionVirginia Commonwealth University · DM1RecruitingVRTXCollaboratorDYNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimateNo phase registeredNCT03458832Clinical Trial Readiness to Solve Barriers to Drug Development in FSHDUniversity of Kansas Medical Center · Facioscapulohumeral Muscular DystrophyActive, not recruitingDYNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimateNo phase registeredNCT04635891Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)University of Kansas Medical Center · FSHDRecruitingDYNCollaboratorNVSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner